Literature DB >> 8317543

Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene.

S K Huang1, F J Martin, G Jay, J Vogel, D Papahadjopoulos, D S Friend.   

Abstract

Transgenic mice bearing the HIV tat gene develop dermal lesions resembling a common malignant tumor in AIDS, Kaposi's sarcoma (KS). To evaluate the permeability characteristics of these lesions and the therapeutic potential of drug-carrying liposomes, we have studied the localization of sterically stabilized liposomes, which show long circulation time in blood and increased accumulation in tumors. Liposomes encapsulating colloidal gold were injected intravenously into transgenic mice bearing KS lesions, and tissues were processed 24 hours later for both electron microscopy and for light microscopy with silver enhancement. Liposomes and silver marker were detected predominantly in the dermis surrounding the early and mature KS lesions, which were characterized by a proliferation of fibroblast-like spindle cells and abnormal blood vessels close to the epidermis. The silver-enhanced gold marker often surrounded vascular channels and scattered erythrocytes. As determined by electron microscopy, some spindle cells and macrophages had ingested intact liposomes. Transendothelial transport of liposomes was observed both through open channels between endothelial cells and also through endothelial cells lining intact vessels. Both extravasation and transcytosis of liposomes through irregular endothelium were much higher in KS lesions than in the adjacent normal skin. The high accumulation of sterically stabilized liposomes in KS lesions and their intracellular uptake by some spindle cells enhances their potential as carriers of chemotherapeutic agents against this neoplasm.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317543      PMCID: PMC1886946     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  12 in total

1.  Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times.

Authors:  D D Lasic; F J Martin; A Gabizon; S K Huang; D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1991-11-18

2.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Authors:  D Papahadjopoulos; T M Allen; A Gabizon; E Mayhew; K Matthay; S K Huang; K D Lee; M C Woodle; D D Lasic; C Redemann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 3.  A review of Kaposi's sarcoma.

Authors:  J Armes
Journal:  Adv Cancer Res       Date:  1989       Impact factor: 6.242

4.  Large unilamellar liposomes with low uptake into the reticuloendothelial system.

Authors:  T M Allen; A Chonn
Journal:  FEBS Lett       Date:  1987-10-19       Impact factor: 4.124

5.  Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid.

Authors:  E G Mayhew; D Lasic; S Babbar; F J Martin
Journal:  Int J Cancer       Date:  1992-05-08       Impact factor: 7.396

6.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.

Authors:  J Vogel; S H Hinrichs; R K Reynolds; P A Luciw; G Jay
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

7.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.

Authors:  S K Huang; E Mayhew; S Gilani; D D Lasic; F J Martin; D Papahadjopoulos
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

9.  Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes.

Authors:  A A Gabizon
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

10.  Kaposi's sarcoma in acquired immune deficiency syndrome (AIDS).

Authors:  N D Francis; J M Parkin; J Weber; A W Boylston
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

View more
  24 in total

1.  Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.

Authors:  H Sakai; H Horinouchi; K Tomiyama; E Ikeda; S Takeoka; K Kobayashi; E Tsuchida
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Degradation kinetics and mechanism of RH1, a new anti-tumor agent: a technical note.

Authors:  Neera Jain; Stephen G Machatha; S Esmail Tabibi; Samuel H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2007-03-02       Impact factor: 3.246

3.  Increased liposome extravasation in selected tissues: effect of substance P.

Authors:  J Rosenecker; W Zhang; K Hong; J Lausier; P Geppetti; S Yoshihara; D Papahadjopoulos; J A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue.

Authors:  R M Schiffelers; G Storm; I A Bakker-Woudenberg
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

5.  Internalization of microbubbles by tumor cells in vivo and in vitro.

Authors:  E Barbarese; S Y Ho; J S D'Arrigo; R H Simon
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

6.  Long-term pharmacokinetics of doxorubicin HCl stealth liposomes in patients after polychemotherapy with vinorelbine, cyclophosphamide and prednisone (CCVP).

Authors:  W Linkesch; M Weger; I Eder; H W Auner; C Pernegg; C Kraule; M J Czejka
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jul-Sep       Impact factor: 2.441

7.  Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy.

Authors:  James I Griffin; Guankui Wang; Weston J Smith; Vivian P Vu; Robert Scheinman; Dominik Stitch; Radu Moldovan; Seyed Moein Moghimi; Dmitri Simberg
Journal:  ACS Nano       Date:  2017-10-18       Impact factor: 15.881

8.  Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy.

Authors:  Dandan Guo; Changying Shi; Xu Wang; Lili Wang; Shengle Zhang; Juntao Luo
Journal:  Biomaterials       Date:  2017-06-30       Impact factor: 12.479

9.  Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell line.

Authors:  Mohsen Rashidi; Alireza Ahmadzadeh; Seyed Ali Ziai; Mahsa Narenji; Hamidreza Jamshidi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-12       Impact factor: 2.416

Review 10.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.